Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 8,130 | 7,922 | 9,619 | 11,564 | 11,336 |
| Operating Income | -8,130 | -7,922 | -9,619 | -11,564 | -11,336 |
| Interest Expense | 5 | 4 | 7 | 6 | 13 |
| Other Income | 282 | 499 | 267 | 236 | -353 |
| Pre-tax Income | -7,853 | -7,426 | -9,360 | -11,334 | -11,702 |
| Income Tax | 7 | 7 | -5 | 12 | 6 |
| Net Income Continuous | -7,860 | -7,434 | -9,355 | -11,346 | -11,708 |
| Net Income | $-7,860 | $-7,434 | $-9,355 | $-11,346 | $-11,708 |
| EPS Basic Total Ops | -0.26 | -0.25 | -0.34 | -0.48 | -0.52 |
| EPS Basic Continuous Ops | -0.26 | -0.25 | -0.33 | -0.48 | -0.52 |
| EPS Diluted Total Ops | -0.26 | -0.25 | -0.34 | -0.48 | -0.52 |
| EPS Diluted Continuous Ops | -0.26 | -0.25 | -0.33 | -0.48 | -0.52 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.25 | -0.35 | N/A | N/A |
| EBITDA(a) | $-8,130 | $-7,922 | $-9,619 | $-11,564 | $-11,336 |